Plné znění - 2/2008 Sb. m. s.

Xxxxxxxxxxxx xxxxxxxxxxxx xxxx xxxxxxx, xx xxx 16. xxxxxxxxx 2007 bylo generálním xxxxxxxxx XXXXXX, depozitářem Xxxxxxxxxxx xxxxxx xxxxx xxxxxxx xx xxxxxx¹⁾, xxxxxxxx xxxxxxxxx xxxxxx xxxxx Přílohy I - Xxxxxxx xxxxxxxxxx látek x xxxxx xxxxxxx.

Xxxxxxx I vstoupila x platnost v xxxxxxx s článkem 34 xxxx. 3 Xxxxxx xxx 1. ledna 2008 x xxxxx xxxx xxxxxxxxx x xxxxxxxx i xxx Xxxxxx xxxxxxxxx. Dnem xxxxxx Xxxxxxx X x xxxxxxxx xxxxxxxx xxxxxx Xxxxxxx X Xxxxxxxxxxx úmluvy proti xxxxxxx xx sportu xx xxxxx xxx xxx 2007, xxxxxxxxx xxx x. 59/2007 Xx. m. x.

Xxxxxxxx xxxxx Přílohy X x xxxx xxxxxxx do českého xxxxxx xx xxxxxxxxx xxxxxxxx.

X1. XXXXXXXXXX LÁTKY

Xxxxxxxxxx xxxxx xxxx xxxxxxxx.

1. XXXXXXXXXX XXXXXXXXXX STEROIDY (XXX):

x. Xxxxxxxx * XXX, xxxxxxxxxx:

1-androstendiol (5α-xxxxxxx-1-xx-3β,17β-xxxx); 1-androstendion (5α-androst-1-en-3,17-dion); xxxxxxxxx (19-norandrostendiol); bolasteron; xxxxxxxx; boldion (xxxxxxxx-1,4-xxxx-3,17-xxxx); xxxxxxx (17α-xxxxxxx-17β-xxxxxxxxxxxxxx-4-xxx[2,3-x]xxxxxxxx); dehydrochlormethyltestosteron (4-xxxxxx-17β-xxxxxxx-17α-xxxxxxxxxxxxx-1,4-xxxx-3-xx); desoxymethyltestosteron (17α-metyl-5α-androst-2-en-17β-ol); xxxxxxxxxxx; ethylestrenol (19-nor-17α-pregn-4-en-17-ol); xxxxxxxxxxxxxx; xxxxxxxxxx; xxxxxxxxx (17β-xxxxxxx-17α-xxxxx-5α-xxxxxxxxxx[2,3-x]-xxxxxxx); gestrinon; 4-hydroxytestosteron (4,17β-xxxxxxxxxxxxxxxx-4-xx-3-xx); kalusteron; xxxxxxxxx; xxxxxxxxxx; xxxxxxxxxx; metandienon (17β-xxxxxxx-17α-xxxxxxxxxxxxx-1,4-xxxx-3-xx); xxxxxxxxx; methandriol; xxxxxxxxxx (2α, 17α-xxxxxxx-5α-xxxxxxxxx-3-xx-17β-xx); xxxxxxxxxxxxxx (17β-xxxxxxx-17α-xxxxxxxxxx-4,9-xxxx-3-xx); xxxxxx-1-xxxxxxxxxxx (17β-xxxxxxx-17α-xxxxx-5α-xxxxxxx-1-xx-3-xx); xxxxxxxxxxxxxxxxxxxx (17β-xxxxxxx-17α-xxxxxxxxx-4-xx-3-xx); xxxxxxxxxxxxxxx (17β-hydroxy-17α-metylestra-4,9,11-trien-3-on); xxxxxxxxxxxxxxxxx; xxxxxxxxx; nandrolon; 19-norandrostendion (xxxx-4-xx-3,17-xxxx); xxxxxxxxxx; norethandrolon; xxxxxxxxxxxx; oxabolon; oxandrolon; xxxxxxxxxxx; xxxxxxxxxx; xxxxxxxxxxx ([3,2-x]xxxxxxx-5α-xxxxxxxxxxxxxx-17β-xxxxxxxxxxxxxxxxx); xxxxxxxxx; xxxxxxxxxx; xxxxxxxxx; 1-xxxxxxxxxxx (17β-xxxxxxx-5α-xxxxxxx-1-xx-3-xx); xxxxxxxxxxxxxxxxxxx (18α-xxxx-xxxxxx-4,9,11-xxxxx-17β-xx-3-xx); trenbolon x xxxxx xxxxx x xxxxxxxx chemickou xxxxxxxxxx nebo xxxxxxxxx xxxxxxxxxxxx účinky.

x. Xxxxxxxxx ** AAS:

Xxxxxxxxxxxxx (androst-5-en-3β,17β-diol), androstendion (xxxxxxx-4-xx-3,17-xxxx), xxxxxxxxxxxxxxxxxx, xxxxxxxxx (xxxxxxxxxxxxxxxxxxxxx, DHEA), xxxxxxxxxxx x xxxxxxxxxxx xxxxxxxxxx x xxxxxxx:

5α-xxxxxxxxx-3α,17α-xxxx xxxxxxx-5-xx-3β,17α-xxxx

5α-xxxxxxxxx-3α,17β-xxxx 4-xxxxxxxxxxxxx (androst-4-en-3β,17β-diol)

5α-xxxxxxxxx-3β,17α-xxxx 5-xxxxxxxxxxxxx (xxxxxxx-5-xx-3,17-xxxx)

5α-androstan-3β,17β-diol epi-dihydrotestosteron

xxxxxxx-4-xx-3α,17α-xxxx 3α-xxxxxxx-5αxxxxxxxxx-17-xx

xxxxxxx-4-xx-3α,17β-xxxx 3β-xxxxxxx-5αxxxxxxxxx-17-xx

xxxxxxx-5-xx-3β,17α-xxxx 19-xxxxxxxxxxxxxx

androst-5-en-3α,17α-diol 19-noretiocholanolon

xxxxxxx-5-xx-3α,17β-xxxx

V xxxxxxxxx, xxx xxxx xxxx produkovat xxxxxxxxxx xxxxxxxxxx steroid přirozeně, xxxx xx xxx xx to, xx Xxxxxx obsahuje tuto Xxxxxxxxx xxxxx x xxxx xxxxxx xxxxxxxxx Xxxxxxxxx laboratorní xxxxx, xxxx xx koncentrace Xxxxxxxx xxxxx xxxx xxxxxx metabolitů xxxx xxxxxxxxxxx a/nebo xxxx xx xxxxxxxx xxxx xxxxxxxxx xxxxx ve Xxxxxx Sportovce významně xxxxxxxxx xx rozmezí xxxxxx, xxxxx xx xxxxxxxx xxxxxxxxx x xxxx xxx, že xxxxxxxxxx xxxxxxxx xxxxxxxxx xxxxxxxx. Nebude xx xxx xx xx, xx Xxxxxx xxxxxxxx Xxxxxxxxx látku v xxxxxxx xxxxxxx, xxxxx Xxxxxxxxx xxxxxxx, že xx xxxxxxxxxxx Xxxxxxxx xxxxx xxxx jejích xxxxxxxxxx xxxx xxxxxxxxxx x/xxxx příslušný poměr xx Xxxxxx Xxxxxxxxx xxxxxxxx xxxxxxxxxxxxx xxxx xxxxxxxxxxxx stavem.

Bude xx mít za xx, xx Xxxxxx Xxxxxxxxx xxxxxxxx Xxxxxxxxx xxxxx x xxxxxxxxx xxxxxxx Pozitivní xxxxxxxxxxx xxxxx xx všech xxxxxxxxx x při xxxxxxxxx xxxxxxxxxxx, xxxxx xxx podle spolehlivé xxxxxxxxxx xxxxxx (xxxx. XXXX) xxxxxxxx, xx xx Xxxxxxxx xxxxx xxxxxxxxxx xxxxxx. X xxxxxxx xxxxxxx není xxxxx xxxxxxxx xxxxx xxxxxxx.

Xxxx xx xxxxxxx xxxxxxxx xxxxxxx xxxxxxxx xxxxxxxxxxx od xxxxxxx xxxxxx, xxxxx xx normálně vyskytují x xxxx x xxxxx xxxxxxxxxx xxxxxxxxxx xxxxxx (např. XXXX) xxxxxxxxxxx xxxxxxxx xxxxx Xxxxxxxx xxxxx, xxx xxxxxxxx xxxxxx xxxxxxx Xxxxxxxx látky, xxxx xxxx. porovnání x xxxxxxxxxxx xxxxxxxxxxxx xxxxxxxxxxx xxxxxxx, xxxx xxxx xxxxxxxxx xxxxxxxxx poměr X/X xxxxx xxx xxxxx (4) xx xxxxx (1) a xxxxx spolehlivá xxxxxxxxxx xxxxxx (xxxx. XXXX) xxxxxxxxxxx xxxxxxxx xxxxx xxxxx, provede xxxxxxxxx Xxxxxxxxxxxxx xxxxxxxxxx další xxxxxxx porovnáním xxxxxxxx xxxxxxxxxx xxxxx xxxx xxxxxxxxxx xxxxxxxxxx xxxxx.

Xx-xx xxxxxxxxxx xxxxxx xxxxx xxxxxxx, xxx xxxxxxxx xxxx laboratoří xxxxxx jako xxxxxxxxx x ne jako xxxxxxxxx. Pokud xxxxxxxxx xxxxxxx, za xxxxxxx xxxxxxxxxx xxxxxxxxxx xxxxxx (xxxx. XXXX) xxxxxxxx xxxxx Zakázané xxxxx, xxxx xxxxx xxxxxxxx xxxxx šetření, x xxxx xx xxx xx to, xx Xxxxxx xxxxxxxx Xxxxxxxxx xxxxx. Xxxxx nebyla xxxxxxx spolehlivá xxxxxxxxxx xxxxxx (xxxx. XXXX) x xxxxxx k xxxxxxxxx xxxxxxxxx 3 xxxxxxxxx testy, bude xxxxxxx xxxxxxxxxxxxxx profil Xxxxxxxxx xxx, xx xxxx příslušnou Xxxxxxxxxxxxxx xxxxxxxxxx x xxxxxxxxxxxxx 3 xxxxxxxx třikrát xxxxxxxx xxx předchozího xxxxxxxx. Xxxxxxxx, který xxxxxxxxxx xxxx xxxxxxxxxxxxxx xxxxxx, bude hlášen xxxx xxxxxxxxx. Xxxxx xxxxxxxxxxxxxx xxxxxx Sportovce, xxxxxxxx xxxxxxxxxx xxxxx, xxxx fyziologicky normální, xxxx se xxx xxxxxxxxx za Pozitivní xxxxxxxxxxx xxxxx.

X xxxxxxxx vzácných xxxxxxxxxxxxxx xxxxxxxxx může xxx x xxxx trvale xxxxxxx boldenon xxxxxxxxxxx xxxxxx ve xxxxxx xxxxxx koncentracích (xx/xx). Xxxxx laboratoř xxxxxx xxxxx xxxxxxxxx x xxxxxxx xxxxxxxxxx analytické xxxxxx (např. XXXX) xxxxxxxxxxx xxxxxxxx xxxxx Xxxxxxxx látky, xxxx xxx provedeno další xxxxxxx xxxxxxxxxx následného xxxxx (xxxxxxxxxx xxxxx).

Xxxxx xxxxxxxxx xxxxxxxxx Xxxxxxxxx xxxxxxxxxxx xxxxx 19-xxxxxxxxxxxxxxx, bude xx xx xxxxxxxxx za xxxxxxx x přesvědčivý xxxxx xxxxxxxxxx xxxxxx Xxxxxxxx xxxxx. X xxxxxxx xxxxxxx není xxxxx xxxxxxxx xxxxx xxxxxxx.

X xxxxxxx, xx Sportovec nebude xxxxxxxxxxxxx xxx dalších xxxxxxxxx, xxxx se xxx xx to, xx Vzorek Xxxxxxxxx xxxxxxxx Xxxxxxxxx látku.

2. Xxxxxxx anabolické xxxxx, xxxxxxxxxx:

Xxxxxxxxxxx, xxxxxxxxxx xxxxxxxxxx androgenových xxxxxxxxx (XXXX), tibolon, xxxxxxx, xxxxxxxxxx, ale xx x xxxxxxxx xxxxx xx ně.

S2. XXXXXXX X XXXXXXXX XXXXX

Xxxxxxxxxxx látky x xxxxxx xxxxxxxxxx xxxxxxx xxxx xxxxxxxx:

1. Erytropoetin (XXX);

2. Xxxxxxx xxxxxx (xXX), insulinu xxxxxxx xxxxxxx xxxxxxx (xxxx. XXX-1), xxxxxxxxxx růstové xxxxxxx (MGF);

3. Xxxxxxxxxxxxx (xxxx. LH, xXX), xxxxxxxx xxx x xxxx;

4. Xxxxxxxx;

5. Kortikotropiny

x xxxxx látky x xxxxxxxx xxxxxxxxx xxxxxxxxxx xxxx xxxxxxxxx xxxxxxxxxxxx účinky.

Xxxxx Xxxxxxxxx nemůže xxxxxxxx, xx koncentrace xxxx xxxxxxxxx fyziologickým xx xxxxxxxxxxxx xxxxxx, xxxx xx xxx xx xx, xx Xxxxxx xxxxxxxx Xxxxxxxxx xxxxx (xxx xx uvedeno xxxx) v xxxxxxxxx, xxx koncentrace Xxxxxxxx xxxxx nebo jejích xxxxxxxxxx xx indikátorů x/xxxx příslušné xxxxxx xx Xxxxxx Xxxxxxxxx xxxxxxx xxxxxxxx xxxxxxx xxxxxxxx xxxxxxxx x xxxx xxx, xx xxxxxxxxxxxx xxxxxxxx endogenní xxxxxxxx.

Xxxxx laboratoř xxxxxxxxx, xx užití xxxxxxxxxx xxxxxxxxxx xxxxxx, xx Xxxxxxxx xxxxx xx xxxxxxxxxx xxxxxx, xxxx se xxx xx to, xx Xxxxxx xxxxxxxx Zakázanou xxxxx a bude xxxxxxx Xxxxxxxxx xxxxxxxxxxx xxxxx.

X3. XXXX-2 XXXXXXXX

Všichni xxxx-2 xxxxxxxx xxxxxx xxxxxx X- x X-xxxxxxx xxxx zakázáni.

Xxxxxxxx xxxx formoterol, xxxxxxxxxx, salmeterol x xxxxxxxxxx, xxx které xx xxx inhalaci xxxxx xxxxxxx xxxxxxxx xxxxxxxxxxxx xxxxxxx.

X xxxx xxxx xxxxxxx xxxxxxxx forma xxxxxxxxxxxx xxxxxxx, bude nález xxxxxxxxxxx (xxxxx xxxx xxxxxxxxxx) xxxxx xxx 1000 xxxxxxxxx x 1 xxxxxxxxx xxxx xxxxxxxxx za Xxxxxxxxx xxxxxxxxxxx xxxxx, xxxxx Xxxxxxxxx xxxxxxxxx, xx xxxxxxxxxx výsledek xxx xxxxxxxx xxxxxxxxxxxxx xxxxxxxx xxxxxxxxxxx x xxxxxxxx.

S4. ANTAGONISTÉ X XXXXXXXXXX HORMONŮ

Xxxxxxxxxxx xxxxxxx xxxx xxxxxxxx:

1. Inhibitory xxxxxxxx, xxxxxxxxxx:

2. Selektivní modulátory xxxxxxxxxxxxx xxxxxxxxx (SERM), xxxxxxxx:

3. Xxxxxxx antiestrogenní látky xxxxxxxxxx:

4. Xxxxx xxxxxxxxxxxx xxxxxx xxxxxxxxxx včetně xxxxxxxxxx xxxxxxxxxx, ale ne x xxxxxxxx pouze xx xx.

X5. DIURETIKA X XXXXXXX XXXXXXXXX XXXXX

Maskovací látky xxxx xxxxxxxx. Zahrnují:

Xxxxxxxxx*, epitestosteron, xxxxxxxxxx, xxxxxxxxxx xxxx-xxxxxxxxx (např. xxxxxxxxxx, dutasterid), xxxxxxxxxxxxxxx (xxxx. xxxxxxx, xxxxxxx, xxxxxxxxxxxxxxxxx) x xxxxx xxxxx s xxxxxxxxx xxxxxxxxxxxx účinky.

Xxxxxxxxx xxxxxxxx:

Acetazolamid, xxxxxxxx, xxxxxxxxx, xxxxxxxxx, xxxxxxxxxxxx, xxxxxxxxx, xxxxxxxx, kyselina xxxxxxxxxx, xxxxxxxxx, xxxxxxxxxxxxx, xxxxxxxx (xxxx. bendroflumethiazid, xxxxxxxxxxxxxxxxxx, xxxxxxxxxxxxx), xxxxxxxxxx x xxxxx xxxxx x podobnou xxxxxxxxx xxxxxxxxxx xxxx xxxxxxxxx xxxxxxxxxxxx xxxxxx (kromě xxxxxxxxxxxx, který není xxxxxxxx).

* Xxxxxxxxxxxx xxxxxxx xxxx xxxxxx, xxxxx xxx Sportovce xxxxxxxx xxxxxxxxx ve xxxxxxx s xxxxxxxx xxxx podprahovou xxxxxxxx xxxx Xxxxxxxx xxxxx (xxxxx).

X1. ZVYŠOVÁNÍ XXXXXXX XXXXXXX

Zakázané xx xxxxxxxxxxx:

M2. CHEMICKÁ X FYZIKÁLNÍ MANIPULACE

X3. XXXXXX XXXXXX

Xxxxxxxxxxxxxx xxxxxxx xxxxx, genů, xxxxxxxx xxxxxxxx, xxxx xxxxxxxxxx xxxxxxx xxxx, xxxxx xxxx xxxxxxxxx xxxxxx xxxxxxxxx xxxxx, xx zakázané.

X6. XXXXXXXXXXX

Všechna xxxxxxxxxxx (xxxxxx obou xxxxxx xxxxxxxxxx optických (X- x X-) xxxxxxx) xxxx xxxxxxxx, x xxxxxxxx xxxxxxxx xxxxxxxxx v xxxxxxx xxxxxx xxxxxxxx xxxxx x xxxxxxxxxxx xxxxxxxxxx xx Monitorovacího programu xxx rok 2008.

Xxxxxxxxxxx xxxxxxxx:

Xxxxxxxxx, xxxxxxxxx**, xxxxxxxxxx, amfetaminil, xxxxxxxxxx, amfetamin, xxxxxxxxxxx, xxxxxxxxxxxxxxx, xxxxxxxxx, xxxxxxxxxx, xxxxxxxxxxxxxxxxx, xxxxxxx****, xxxxxxxx, xxxxxxxxx, xxxxxxxxxxxxxx, famprofazon, xxxxxxxxxxx, xxxxxxxxxxxxx, fenetylin, xxxxxxxxxxx, fenkamfamin, xxxxxxxx, xxxxxxxxxxx, xxxxxxxxxxxxx, xxxxxxxxxxx, xxxxxxxxx, 4-xxxxxxxxxxxxxx (xxxxxxxx), xxxxxxxxxx, xxxxxxxxxx, xxxxxxxxxxxx, xxxxx***, xxxxxxxxxxx, xxxxxx, xxxxxxxxxxx, xxxxxxxxxx, levmetamfetamin, xxxxxxxxx, mefentermin, meklofenoxát, xxxxxxxxxxxx (D-), xxxxxxxxxxxx****, xxxxxxxxxxxxxxxxxxxxxx, methylendioxymetamfetamin, xxxxxxxxxxxxx, xxxxxxxx, xxxxxxxxx, niketamid, xxxxxxxxxxx, xxxxxxxxxxxxxx, xxxxxxxxx, xxxxxxxxx, oxilofrin, parahydroxyamfetamin, xxxxxxx, xxxxxxxxxxx, x-xxxxxxxxxxxxxxx, xxxxxxxxx, propylhexedrin, xxxxxxxxx, xxxxxxxxxx, xxxxxxxxx, tuaminoheptan x další xxxxx x xxxxxxxx xxxxxxxxx xxxxxxxxxx xxxx podobnými xxxxxxxxxxxx xxxxxx.

Xxxxxxxxxxxx xxxxxxxxx xxxxxxxx xxxx xxxxxxxx v xxxxx xxxxxx bude xxxxxxxxxx xx xxxxxxxxxxx xxxxx xxxxx, xxxxx Xxxxxxxxx xxxxxxx, xx xxxx xxxxxxxxx dostupnost x běžných xxxxxxxxx xxxxxxxxxxx xxxxxxxx xxxxxxxxx xxxxxxxx xxxxxxxxxxxxxxx xxxxxxxx, xxxx xx u xxx menší xxxxxxxxxxxxxxx, xx xxxx xxxxxxx xxxxxxxx xxxx dopingová xxxxx.

S7. XXXXXXXXX

Xxxxxxxxxxx xxxxxxxxx xxxx xxxxxxxx:

Xxxxxxxxxxx, xxxxxxxxxxxxx, xxxxxxxxx(xxxxxx), xxxxxxxx x xxxx deriváty, xxxxxxxxxxx, xxxxxxx, xxxxxx, xxxxxxxx, xxxxxxxxx, pentazocin, xxxxxxx.

X8. XXXXXXXXXXX

Kanabinoidy (xxxx. xxxxx, xxxxxxxxx) jsou xxxxxxxx.

X9. XXXXXXXXXXXXXXXXXXXX

Xxxxxxx xxxxxxxxxxxxxxxxxxxx xxxxxxxx xxxxxx, xxxxxxxx, xxxxxxxxxx xxxx nitrosvalovou xxxxxxxx jsou zakázané. Xxxxxx xxxxx xxxxxxxx xxxxxxxxxxxxx xxxxxxx.

Xxxx xxxxxxx injekční xxxxxxxx (xxxxxxxxxxxx, do xxxxx xxxxxx, xx okolí xxxxxx, xxxxxxxxxx, xx xxxx) x inhalační xxxxxxxx vyžadují zkrácenou xxxxxxxxxxxxx xxxxxxx x xxxxxxxx xxxx uvedených.

Xxxxxxx xxxxxxxxx podávané xx potíže xxxxx (xxxxxx xxxxxxxxxxx/xxxxxxxxxx), ušní, xxxxx, oční, potíže xxxxx řitního xxxxxx, xxxxxxxx xxx x xxxxx xxxxxx xxxxxxxx x xxxxxxxxxx xxxxxx xxxxx terapeutické xxxxxxx.

P1. XXXXXXX

Xxxxxxx (etanol) xx xxxxxxxx pouze Xxx xxxxxxx x xxxxxxxxxxxxx xxxxxxxx. Detekce xx xxxx xxxxxxxx xxxxxxxx xxxxxxxx x/xxxx xxxxxxxx krve. Xxxxxxx xxxxxxx pro porušení xxxxxxxxxxx xxxxxxxx (hematologická xxxxxxx) xx pro xxxxxx federaci xxxxxxx x xxxxxxxxx.

∙ Xxxxxxxxxxxx xxxxx (XXX) (0.10 x/x)

∙ Xxxxxx (WKF) (0.10 x/x)

∙ Xxxxxxx xxxxxx x xxxxxxxxxxxx (XXX) (0.20 g/l)

∙ Xxxxxxxxxxx (XXXX, XXX) (0.10 x/x)

∙ Xxxxxxx xxxxxxx (XXXX) xxx xxx xxxxxxxxxx se xxxxxxxx (0.10 g/l)

∙ Motocyklový xxxxx (XXX) (0.10 g/l)

∙ Xxxxx xxxxxxxxxx (XXX) (0.30 g/l)

∙ Kuželky (XXX) (0.10 g/l)

X2. XXXX-XXXXXXXXX

Xxxxx xxxx xxxxx xxxxxx, xxxx-xxxxxxxxx xxxx zakázány xxxxx Při xxxxxxx x následujících xxxxxxxx.

∙ Xxxxxxxxxxxx xxxxx (XXX)

∙ Xxxxxxxx (XXXX)

∙ Boby (XXXX)

∙ Xxxxx (XXX)

∙ Xxxxxxx (XXX)

∙ Xxxxxxxxxx (XXX)

∙ Jachting (XXXX) - "xxxxx xxxx" - jen xxxxxxxxxxx

∙ Kuželky (XXX)

∙ Xxxxxxx xxxxxx a parašutismus (XXX)

∙ Xxxxxxxxxxx (XXXX, XXX) (xxxxxxxx xxxx Xxxx xxxxxx)

∙ Xxxxxxxx (XXX) - skoky xx xxxxxx x akrobatické xxxxxxxx-xxxxx a U-rampa, x snowboard X-xxxxx x "xxx xxx"

∙ Moderní pětiboj (XXXX) - xxx xxxxxxxxxx xx střelbou

∙ Motocyklový sport (XXX)

∙ Xxxxxxxx x obdobné xxxxxx (XXXX, XXX "bowls")

∙ Střelba (ISSF, XXX) (xxxxxxxx xxxx Xxxx soutěž)

∙ Xxxxx xxxxxxxxxx (XXX)

∙ Xxxxx (XXXX)

Xxxx-xxxxxxxxx zahrnují xxxxxxxxxxx xxxxx:

Acebutolol, xxxxxxxxxx, xxxxxxxx, xxxxxxxxx, xxxxxxxxxx, xxxxxxx, xxxxxxxxxx, xxxxxxx, xxxxxxxxx, xxxxxxxxxx, xxxxxxxxx, xxxxxxxxxxx, xxxxxxxxxxxx, xxxxxxxxxx, xxxxxxx, oxprenolol, xxxxxxxx, xxxxxxxxxxx, xxxxxxx, xxxxxxx, xxx ne s xxxxxxxx xxxxx na xx

"Xxxxxxxxxx látky"* xxxx vyjmenovány níže:

∙ Xxxxxxx Xxxx-2 xxxxxxxx v inhalaci, xxxxx xxxxxxxxxxx (volného xxxx xxxxxxxxxxx) při xxxxxxxx xxxxxx než 1000 xx/xx xxxx x xxxxxxxxxxxx (xxxxxxx xx xxxxxxx X 1.2 Xxxxxxx xxxxxxxxxx xxxxx);

∙ Inhibitory xxxx-xxxxxxxxx, xxxxxxxxxx;

∙ Xxxxx, kropropamid, xxxxxxxxxx, xxxxxxx, xxxxxxxx, xxxxxxxxxxx, xxxxxxxxxxxxx, xxxxxxxxxx, isomethepten, xxxxxxxxxxxxxxx, xxxxxxxxxxxx, x-xxxxxxxxxxxxxx, xxxxxxxxxxxx, xxxxxxxxx, norfenefrin, xxxxxxxxx, ortetamin, xxxxxxxxx, xxxxxxxxxxxxxx, selegilin, xxxxxxxxxx, xxxxxxxxxxxxx x xxxxxxx xxxxxxx xxxxxxxxxxx xxxxxxxxx xxxxxxxx x xxxxxx X6, xxx která Xxxxxxxxx xxxxxxx, že xxxxxxx podmínky popsané x oddíle X6;

∙ Kanabinoidy;

∙ Xxxxxxx Xxxxxxxxxxxxxxxxxxxx;

∙ Xxxxxxx;

∙ Xxxxxxx Xxxx-xxxxxxxxx.

*"V Xxxxxxx xxxxx xxx xxxxxxxxxxx xxxxxxxxxx xxxxx, které xxxxxxxx umožňuji neúmyslné xxxxxxxx xxxxxxxxxxxxxxx xxxxxxxx, xxxxxxx xxxx xxxxxxxxx xxxxxxxx x xxxxxxx xxxxxxxxx xxxxxxxxxxx, nebo x nichž xx xxxxx xxxxxxxxxxxxxxx, že xxxxx xxxxxxx zneužity xxxx xxxxxxxxx činidla." Xxxxxxxx antidopingového xxxxxxxx xxxxxxxxxx xxxxxxxx xxxxx xxxx xxxxxxxx snížený xxxxxx xx předpokladu, xx "...Xxxxxxxxx xxxx xxxxx xxxxxxxx, xx Xxxxxxx specifické xxxxx xxxxxx zamýšleno ke xxxxxxx xxxxxxxxxxx xxxxxx...".

Xxxxxx xxxxxxx č. 2/2008 Xx. m. x. xxxxx xxxxxxxxx xxxx 31.1.2008.

Xxxxxx xxxxxxx x. 2/2008 Sb. m. x. xxx xxxxxx xxxxxxx xxxxxxxxx č. 8/2009 Sb. m. s. x xxxxxxxxx xx 7.2.2009.

Xxxxx xxxxxxxxxxxx xxxxxxxx norem xxxxxx xxxxxxxx xxxxxxxx x odkazech xxxx xxxxxxxxxxxxx, pokud se xxxx netýká xxxxxxxxx xxxxx shora xxxxxxxxx xxxxxxxx předpisu.